Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-766P is a **pseudogene** related to the highly conserved U6 small nuclear RNA (U6 snRNA) family. Genuine U6 snRNA is a core component of the spliceosome, participating in pre-mRNA splicing in the nucleus[1][3]. Pseudogenes such as RNU6-766P, found throughout vertebrate genomes, are non-functional remnants or processed duplicates of parent snRNA genes and do *not* encode active RNA or protein products[3][5]. These pseudogenes do not engage in canonical biological functions, disease roles, or direct drug interactions and are generally considered genomic "back-ups" or evolutionary byproducts[3]. There are no known implications for patient selection, therapeutic efficacy, or safety based on the pseudogene RNU6-766P. The nomenclature and classification are correct for a non-functional, non-target molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 766, pseudogene (RNU6-766P).